share_log

ICoreConnect Inc. Announces Expansion of Endorsement Collaboration With the Rhode Island Dental Association

ICoreConnect Inc. Announces Expansion of Endorsement Collaboration With the Rhode Island Dental Association

iCoreConnect Inc. 宣佈擴大與羅德島牙科協會的代言合作
GlobeNewswire ·  01/18 21:00

Seven Additional Endorsements, Including Recent Product Launches

另外七項代言,包括近期發佈的產品

OCOEE, FL, Jan. 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – iCoreConnect Inc. (NASDAQ: ICCT)("iCore" or the "Company"), a leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform, announced today the expansion of its collaboration with the Rhode Island Dental Association ("RIDA") with seven new endorsements of iCore offerings. This strategic collaboration marks another step forward in iCore's mission to provide innovative solutions and advanced technologies that cater to the evolving needs of customers and state association members.

佛羅里達州 OCOEE,2024 年 1 月 18 日(GLOBE NEWSWIRE)——通過 NewMediaWire — iCoreConnect Inc.(納斯達克股票代碼:ICCT)(“iCore” 或 “公司”)是一家領先的基於雲的軟件和技術公司,專注於通過其企業和醫療保健工作流程平台提高工作流程生產力和客戶盈利能力。該公司今天宣佈擴大與羅德島牙科協會(“RIDA”)的合作,對iCore產品進行了七項新認可。這種戰略合作標誌着iCore的使命又向前邁出了一步,即提供創新的解決方案和先進技術,以滿足客戶和州協會成員不斷變化的需求。

iCore strives to deliver high-quality products and exceptional services and has quickly become a trusted partner of RIDA since the collaboration began in September of 2023. The expanded collaboration is a testament to the value seen in iCore's solutions by the members of the Rhode Island Dental Association, and the demand for iCore's offerings in the dental industry.

iCore 致力於提供高質量的產品和卓越的服務,自 2023 年 9 月合作開始以來,它已迅速成爲 RIDA 值得信賴的合作伙伴。擴大合作證明了羅德島牙科協會成員對iCore解決方案的價值以及牙科行業對iCore產品的需求。

The expansion of the collaboration will help the Rhode Island Dental Association and its members leverage iCoreConnect's comprehensive suite of SaaS solutions including:

擴大合作將幫助羅德島牙科協會及其成員利用iCoreConnect的全面的SaaS解決方案套件,包括:

  • iCoreVerify
  • iCoreRx & EPCS
  • iCoreHuddle
  • iCoreHIPAA
  • iCoreClaims
  • iCorePay
  • iCoreVeri
  • icoreRx 和 EPCS
  • iCoreHuddle
  • iCoreHIPAA
  • icoreClaims
  • iCorepay

These solutions are designed, and continuously updated, to empower businesses with the tools and capabilities they need to succeed in an ever-changing marketplace.

這些解決方案經過精心設計並不斷更新,旨在爲企業提供在不斷變化的市場中取得成功所需的工具和能力。

"We are excited to expand our collaboration with the Rhode Island Dental Association from the initial endorsement of three products to now ten products. This collaboration will allow us to further align our offerings with their strategic goals and support their membership growth aspirations," said Robert McDermott, CEO & President at iCoreConnect. "Our team is committed to delivering tailored solutions that will drive efficiency, innovation, and success for all providers in the healthcare industry."

“我們很高興擴大與羅德島牙科協會的合作,從最初認可的三種產品擴大到現在的十種產品。這種合作將使我們能夠進一步調整我們的產品與他們的戰略目標,並支持他們的會員增長願望。” iCoreConnect首席執行官兼總裁羅伯特·麥克德莫特說。“我們的團隊致力於提供量身定製的解決方案,以提高醫療保健行業所有提供商的效率、創新和成功。”

Aaron Guckian, Executive Director of Rhode Island Dental Association, said, "It only took us a few weeks after we endorsed the first three products to recognize the superior value of iCoreConnect's full iCoreEnterprise platform. Every product and service is designed specifically to help our members with everything from insurance billing and claims, to cloud ePrescribing, and so much more. Our members need access to every product and that's exactly why we immediately expanded our endorsement."

羅德島牙科協會執行董事亞倫·古基安說:“在我們認可前三款產品後,我們僅用了幾周時間就認可了iCoreConnect完整iCoreEnterprise平台的卓越價值。每種產品和服務都是專門爲我們的會員而設計的,從保險賬單和理賠,到雲端電子處方等等,應有盡有。我們的會員需要訪問所有產品,這正是我們立即擴大認可範圍的原因。”

Leveraging product endorsements from State Dental Associations is an integral part of iCore's growth strategy. After receiving endorsement, iCore facilitates a co-branded marketing campaign to get the news out, collaborating with the respective state association to deliver content through print, email campaigns, journals, newsletters, and more.

利用州牙科協會的產品認可是iCore增長戰略不可分割的一部分。獲得認可後,iCore促進了一項聯合品牌的營銷活動以發佈新聞,並與相應的州協會合作,通過印刷、電子郵件活動、期刊、時事通訊等提供內容。

About iCoreConnect Inc. (NASDAQ: ICCT)

關於 iCoreConnect Inc.(納斯達克股票代碼:ICCT)

iCoreConnect Inc. is a leading, cloud-based software and technology company focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. iCoreConnect is most notably known for its innovation in solving healthcare business problems. iCoreConnect's philosophy places a high value on customer feedback, positioning iCoreConnect to respond to the market's needs. iCoreConnect touts a platform of 16 SaaS enterprise solutions and more than 100 product endorsements with state or regional healthcare associations across the United States.

iCoreConnect Inc. 是一家領先的基於雲的軟件和技術公司,專注於通過其企業和醫療保健工作流應用程序和服務平台提高工作流程生產力和實踐盈利能力。iCoreConnect 最著名的是其在解決醫療業務問題方面的創新。iCoreConnect 高度重視客戶反饋,使iCoreConnect能夠應對市場需求。iCoreConnect吹捧一個由16種SaaS企業解決方案和100多項州政府認可的產品組成的平台或者美國各地的地區醫療保健協會。

Forward-Looking Statements

前瞻性陳述

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including 'believes,' 'estimates,' 'anticipates,' 'expects,' 'plans,' 'projects,' 'intends,' 'potential,' 'may,' 'could,' 'might,' 'will,' 'should,' 'approximately' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. "Risk Factors" in the Company's most recently filed Form 10-K filed with the Securities and Exchange Commission ("SEC") and updated from time to time in its Form 10-Q filings and in its other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

本新聞稿中的一些陳述是1933年《證券法》第27A條、1934年《證券交易法》第21E條和1995年《私人證券訴訟改革法》所指的前瞻性陳述,涉及風險和不確定性。儘管公司認爲截至發佈之日,此類前瞻性陳述中反映的預期是合理的,但事實證明,預期可能與此類前瞻性陳述所表達或暗示的結果存在重大差異。該公司試圖通過包括 “相信”、“估計”、“預期”、“計劃”、“項目”、“打算”、“潛力”、“可能”、“可能”、“可能”、“將”、“應該”、“大約” 或其他表示未來事件或結果不確定性的詞語來識別這些前瞻性陳述,以識別這些前瞻性陳述。這些陳述只是預測,涉及已知和未知的風險、不確定性和其他因素,包括在項目1A下討論的因素。公司最近向美國證券交易委員會(“SEC”)提交的10-K表格中的 “風險因素”,並在其10-Q表文件和向美國證券交易委員會提交的其他公開文件中不時更新。本新聞稿中包含的任何前瞻性陳述僅代表截至發佈日期。公司沒有義務更新本新聞稿中包含的任何前瞻性陳述,以反映其發佈日期之後發生的事件或情況,也沒有義務反映意外事件的發生。

Investor Contacts:
Davis Snyder or Nick Nelson
ICCT@alpha-ir.com
312-445-2870

投資者聯繫人:
戴維斯·斯奈德或尼克·納爾遜
ICCT@alpha-ir.com
312-445-2870


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論